SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 140.36 |
| Enterprise Value ($M) | 108.39 |
| Book Value ($M) | 281.20 |
| Book Value / Share | 3.11 |
| Price / Book | 0.50 |
| NCAV ($M) | 174.29 |
| NCAV / Share | 1.92 |
| Price / NCAV | 0.81 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.48 |
| Return on Assets (ROA) | -0.34 |
| Return on Equity (ROE) | -0.40 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.38 |
| Current Ratio | 7.38 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 237.43 |
| Assets | 344.33 |
| Liabilities | 63.13 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Haurwitz Rachel E. | 4.80 | 20.92 | |
| 13G | Bank Of America Corp /de/ | 5.60 | ||
| 13G/A | PFM Health Sciences, LP | 4.80 | ||
| 13G/A | Avidity Partners Management LP | 0.00 | -100.00 | |
| 13G/A | Point72 Asset Management, L.P. | 3.00 | -38.88 | |
| 13G/A | Vanguard Group Inc | 5.11 | 0.00 | |
| 13G/A | State Street Corp | 1.80 | -68.39 | |
| 13G/A | BlackRock, Inc. | 8.00 | 49.69 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 617,028 | 1,758,331 | 35.09 | |
| 781,024 | 2,647,388 | 29.50 | |
| 473,078 | 1,902,977 | 24.86 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| COGT – Cogent Biosciences, Inc. | COLL – Collegium Pharmaceutical, Inc. |
| CPIX – Cumberland Pharmaceuticals Inc. | CRGX – CARGO Therapeutics, Inc. |
| CRNX – Crinetics Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io